[1]
M. I. Karamat, A. A. Khan, and T. Maju, “Prophylactic Role of Intra-Vitreal Bevacizumab(Avastin) in Diabetic Patients Under Going Phacoemulcification”, Annals KEMU, vol. 25, no. 1, Mar. 2019.